Skip to main content
  • Revised Urine Specimen Collector Guidelines Posted Today

    July 07 , 2014 01:34 pm
    Drug test

     

     

    Revised urine specimen collector guidelines were posted today, July 3rd.

    The following are some changes to the revised Urine Speciment Collector Guidelines from the October 1, 2010 version:

    -Updated web site addressses/hyperlinks, as needed

  • DOT: Official Q&As Published

    July 07 , 2014 01:32 pm
    Question

    The Office of Drug and Alcohol Policy and Compliance, with the Office of General Counsel, issued 49 CFR Part 40 Question and Answers. The Q&As explain:

    1.) When may a collector give an employee permission to leave a collection site
    2.) What happens if an employee leaves the collection site prior to the completion of the testing process

    To view all Q&As: http://www.dot.gov/odapc/part40QandA

  • NCADD Fact Sheet: Alcohol and Other Drugs in the Workplace

    July 07 , 2014 01:31 pm
    NCADD

    The NCADD has provided a quick view fact sheet about drugs in the workplace. 

    Click HERE to view the NCADD's Fact Sheet.

  • Hand-Held Treatment for Overdoses is Approved

    June 10 , 2014 01:40 pm
    hand held device

    The FDA has approved a hand-held device called Evzio that can deliver a single dose of naloxone. Naloxone is a medication that reverses the effects of an overdose, commonly used on people who have stopped breathing or lost consciousness from an opioid drug overdose. Until now, naloxone has available only in medical settings, often too late for the drug to be effective.

  • Medications to Help People Stop Drinking are Rarely Prescribed

    June 10 , 2014 01:38 pm
    stop drinking

    The Journal of the American Medical Association conducted a study and found that two medications that could be used to aid in helping people to stop drinking are underutilized. The drugs, Naltrexone and Acamprosate, have been approved by the FDA and have been shown to reduce alcohol craving by altering the brain’s chemical reward system. On the market for more than 10 years, many doctors are not aware of their effectiveness in treating alcoholism.

  • June is National Safety Month

    June 10 , 2014 01:36 pm
    National Safety 2014

    The 2014 National Safety Month theme, "Safety: It takes all of us," was inspired by the idea of continuous risk reduction – a key pillar in the Journey to Safety Excellence.  A successful safety program depends on s

  • Mox-Duo: Newest Pain Drug Soon to be On the Market

    May 14 , 2014 01:44 pm

    The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee is scheduled to meet to discuss the safety and efficacy of MoxDuo, a new morphine sulfate and oxycodone hydrochloride combination. Moxduo will be used to treat moderate to severe acute pain where the use of opioid analgesic is appropriate, according to Pain Medicine News.  If MoxDuo is approved, it’ll be the first combination drug to include two immediate-release opioids. 

  • Anti-Seizure Drug May Reduce Alcohol Consumption

    May 14 , 2014 01:44 pm

    Science Daily reports that in a test study, researchers from Boston University School of Medicine have discovered that the anti-seizure medicine ezogabine has aided in reduced consumption of alcohol in test participants. Excessive alcohol consumption is one of the leading illnesses in the United States and negatively impacts the work environment and productivity of workers. It also causes health care expenses to sky rocket.

  • Addition Treatment and Outcomes

    May 14 , 2014 01:43 pm

    It would seem to make sense that substance use in the workplace, especially when categorized as substance abuse, would negatively affect productivity. However, there has been no definitive correlation between the two in order to demonstrate a positive relationship.

  • Clinical Corner: What is SAP Treatment?

    April 15 , 2014 01:47 pm
    sky

    A common question often asked when discussing SAP services is what type of treatment is associated with the SAP process? In his article originially written for the DATIA Focus, Dr. Reed Morrison discusses why sucessful SAP services don't necessarily need to revolve around treatment recommendations, but rather could be considered a part of Contingency Management intervention. To read the full article: click here

     

  • FMCSA Orders Four Motor Carriers to Shut-down

    April 14 , 2014 01:50 pm
    orange truck

    Four motor carriers were told to shut-down immediately due to disregard of the federal safety regulations put in place by the U.S. Department of Transportation’s Federal Motor Carrier Safety Administration (FMCSA). Three out of the four companies that were shut-down, did not adhere to DOT Regulations CFR 49 Part 40, also known as the Procedures for Transportation Workplace Drug and Alcohol Testing Programs.

  • NCADD Facts About Alcohol in the Workplace

    April 14 , 2014 01:49 pm
    bottle Tops

    • 6.6% of Americans employed in full-time jobs report heavy drinking, defined as drinking five or more

    drinks per occasion on five or more days in the past 30 days; 4.9% of part-timers and 10.4% of unemployed workers also report heavy drinking; the highest percentage of heavy drinkers (12 .2%) is found among unemployed adults ages 26 to 34.'

    • Up to 40% of industrial fatalities and 47% of industrial injuries can be linked to alcohol consumption and alcoholism.'

  • Alcohol Awareness Month

    April 14 , 2014 01:46 pm
    April Alcohol Awareness

    The 2014 theme for NCADD's Alcohol Awareness Month is Help for Today. Hope for Tomorrow. The NCADD hope that with this year's theme, the month with filled with local, state and national awareness initiatives aimed at educating people about the treatment and prevention of alchohol abuse. For more information about National Alcohol Awareness Month, visit the NCADD's website.  

  • CDL Clearinghouse Comments

    March 24 , 2014 01:55 pm
    moving truck

    The proposed rule would require FMCSA-regulated motor carrier employers, Medical Review Officers (MROs), Substance Abuse Professionals (SAPs), and consortia/third party administrators (C/TPAs) supporting U.S.

  • NIDA Updates Heroin Research Report

    March 24 , 2014 01:53 pm
    Heroin

    The National Institute on Drug Abuse (NIDA) has updated it's online heroin research report. The updated report features current statistics as well as treatment options for heroin use disorders. 

  • Synthetic Pot Tied to Emergencies

    March 24 , 2014 01:52 pm
    Emergency Room

    Synthetic marijuana is causing as alarm in Emergency Departments across the country.

  • The FMCSA Safety Measurement System Better Identifies High Risk Carriers

    February 20 , 2014 02:04 pm
    safety

    According to a recent performance study, the FMCSA’s Safety Measurement System (SMS) is more effective at identifying high risk operators than the previous measurement system.

    Two years of pre-SMS data was taken from a subset of carriers.  The historical data was then compared to future crash data and tracked for a period of 18 months.  The resulting analysis indicated that the algorithms used by the SMS would have identified risks and the need for interventions such as road side inspections, on-site investigations and warning letters.

  • Who Determines A Refusal to Test?

    February 20 , 2014 01:58 pm
    Refusal

    Department of Transportation (DOT) safety sensitive employees are required to comply with the Drug and Alcohol Testing Regulations according to 49 CFR Part 40.  An employee is in violation of those regulations when he or she tests positive for a prohibited substance or when their behavior is determined by a DER or MRO to be a refusal to test.

  • What is the Return To Duty SAP Process?

    February 17 , 2014 02:06 pm
    SAP Process

    The Return to Duty SAP Process is required when a DOT regulated safety-sensitive employee is found to be in violation of a DOT mandated drug and/or alcohol test.  A violation occurs when an employee fails a mandated DOT drug test for a prohibited substance or refuses to take the test.  In the event of a violation, the employee must immediately be removed from all safety-sensitive functions and is required to successfully complete the Return to Duty SAP Process in order to regain eligibility to return to safety-sensitive duty for a previous or future employer.

  • FMCSA Proposes Drug and Alcohol Testing Clearinghouse for Commercial Drivers

    February 17 , 2014 02:02 pm
    folders

    As part of its continued efforts to promote and improve public safety, the DOT’s Federal Motor Carrier Safety Administration (FMCSA) proposed a national drug and alcohol testing clearinghouse for all commercial truck and bus drivers on February 12, 2014.  The proposal was part of the Moving Ahead for Progress in the 21st Century Act.  The clearinghouse aims to help identify safety sensitive bus or truck drivers that are in violation of the federal drug and alcohol testing regulations.  According to the FMCSA,

  • 2014 DOT Random Drug and Alcohol Testing Rates

    January 30 , 2014 02:15 pm
    test cup

    The Department of Transportation released the minimum random drug and alcohol testing rates required by each of the operating administrations.  The mandatory testing requirements apply to employers with staff who perform safety sensitive duties within the DOT agencies (Federal Motor Carriers Safety Administration, Federal Aviation Administration, Federal Transit Administration, Federal Railroad Administration, Pipeline and Hazardous Materials Safety Administration) and the United States Coast Guard. 

  • DEA Assigns Temporary Placement of Four Synthetic Cannabinoids Into Schedule I

    January 30 , 2014 02:14 pm
    No Synthetic Cannabinoids

    On January 10, 2014, the Drug Enforcement Administration (DEA) issued a notice of intent to temporarily schedule four synthetic cannabinoids into Schedule I.  The action has been deemed necessary to avoid an imminent hazard to public safety.  The substances are quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB–22QUPIC); quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB–22; 5F–PB–22); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB–FUBINACA); and N-(1-amino-3,3-dimethyl-1-oxobuta

  • FMCSA to Shut Down Carriers with Safety Violations

    January 30 , 2014 02:11 pm
    FMCSA Shut down

    Bus or truck companies with patterns of safety violations are at risk of being shut down by The Federal Motor Carrier Safety Administration (FMCSA).  The FMCSA published a Patterns of Safety Violations Rule that gives the agency the authority to completely revoke a motor carrier’s authority to operate, if the company (or company officer) has a history of deliberately violating federal safety regulations.  These high-risk carriers endanger public safety by avoiding or covering up their negative history of safety compliance.  This rule will be an enforcement tool in the c

  • DEA Assigns Temporary Placement of 10 Synthetic Cathinones Into Schedule I

    January 30 , 2014 02:09 pm
    No Synthetic Cathinones

    The Drug Enforcement Administration (DEA) issued a notice of intent to temporarily schedule 10 synthetic cathinones into Schedule I.  The final order will be published in the Federal Register and may not be effective prior to February 27, 2014. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of these synthetic cathinones. The 10 substances are:

  • National Drug Facts Week

    January 30 , 2014 02:07 pm
    NDFW logo

    The week of January 27 to Feb 2, 2014 is National Drug Facts Week.  Originally launched in 2010 by the National Institute of Drug Abuse (NIDA), the week long health observance aims to educate and inform teens of the realities, threats and myths associated with drug abuse and addiction.  Community based and social media events are planned to raise awareness. 

Contact Us

Call now or complete form & we'll call you!
Learn More About

Sign up to receive our
Newsletter


Positive Drug Test?

ASAP offers quality DOT SAP evaluations and case management services. Our trained and knowledgeable staff work to ensure that each DOT SAP evaluation and case is handled efficiently and according to DOT regulations.